BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 22/07/2022

FDA Announces Draft Guidance for Real-Time Oncology Review Process

The FDA is releasing a draft guidance document outlining the process for submitting new drug and biologics applications with cancer indications for review under its Real-Time Oncology Review program.

Source: Federal Register — Food and Drug AdministrationOpen original release →